research communications\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoSTRUCTURAL BIOLOGY
COMMUNICATIONS
ISSN: 2053-230X

X-ray crystal structure of proliferating cell nuclear antigen 1 from Aeropyrum pernix

crossmark logo

aGraduate School of Life Science and Technology, Iryo Sosei University, Iwaki, Fukushima, Japan, bDepartment of Pharmacy, Fukushima Rosai Hospital, Iwaki, Fukushima, Japan, cGraduate School of Science and Engineering, Iryo Sosei University, Iwaki, Fukushima, Japan, and dFaculty of Pharmacy, Iryo Sosei University, Iwaki, Fukushima, Japan
*Correspondence e-mail: masaru@isu.ac.jp

Edited by A. Nakagawa, Osaka University, Japan (Received 9 July 2024; accepted 26 September 2024; online 9 October 2024)

Proliferating cell nuclear antigen (PCNA) plays a critical role in DNA replication by enhancing the activity of various proteins involved in replication. In this study, the crystal structure of ApePCNA1, one of three PCNAs from the thermophilic archaeon Aeropyrum pernix, was elucidated. ApePCNA1 was cloned and expressed in Escherichia coli and the protein was purified and crystallized. The resulting crystal structure determined at 2.00 Å resolution revealed that ApePCNA1 does not form a trimeric ring, unlike PCNAs from other domains of life. It has unique structural features, including a long interdomain-connecting loop and a PIP-box-like sequence at the N-terminus, indicating potential interactions with other proteins. These findings provide insights into the functional mechanisms of PCNAs in archaea and their evolutionary conservation across different domains of life. A modified medium and protocol were used to express recombinant protein containing the lac operon. The expression of the target protein increased and the total incubation time decreased when using this system compared with those of previous expression protocols.

1. Introduction

DNA replication is a key event in the cell cycle that precedes cell division. It involves various proteins, including DNA-dependent DNA polymerases (Yao & O'Donnell, 2016[Yao, N. Y. & O'Donnell, M. E. (2016). Crit. Rev. Biochem. Mol. Biol. 51, 135-149.]). Among these factors, proliferating cell nuclear antigen (PCNA) forms a trimeric ring (sliding clamp) around DNA and directly enhances the activity of proteins involved in replication (Maga & Hübscher, 2003[Maga, G. & Hübscher, U. (2003). J. Cell Sci. 116, 3051-3060.]). Several enzymes bind to PCNA via the PCNA-interacting peptide-box (PIP-box) motif, including DNA-dependent DNA polymerases, flap endonucleases and DNA ligases involved in DNA replication (MacNeill, 2016[MacNeill, S. A. (2016). Curr. Genet. 62, 527-532.]; Moldovan et al., 2007[Moldovan, G. L., Pfander, B. & Jentsch, S. (2007). Cell, 129, 665-679. ]; Winter & Bunting, 2012[Winter, J. A. & Bunting, K. A. (2012). Archaea, 2012, 951010.]). PCNA has a PIP-box binding site near the C-terminus that is oriented in the direction of DNA replication (Horsfall et al., 2021[Horsfall, A. J., Vandborg, B. A., Kowalczyk, W., Chav, T., Scanlon, D. B., Abell, A. D. & Bruning, J. B. (2021). J. Biol. Chem. 296, 100773.]). Sliding clamps can be considered to be DNA scaffolds that allow specific enzymes (such as DNA polymerase) to bind and catalyze DNA replication.

Sliding clamps are involved in cell proliferation and are frequently expressed in cancer cells (Chen et al., 2021[Chen, X., Sun, J. & Wang, Y. (2021). J. BUON, 26, 72-78.]). They have attracted attention as a potential target for disease diagnosis and treatment (Wendel et al., 2023[Wendel, S. O., Snow, J. A., Gu, L., Banerjee, N. S., Malkas, L. & Wallace, N. A. (2023). J. Med. Virol. 95, e29244.]). Furthermore, bacterial β-subunit (a monomer of the bacterial sliding-clamp complex) inhibitors have been explored to develop new antimicrobial agents (Liu et al., 2021[Liu, B., Li, S., Liu, Y., Chen, H., Hu, Z., Wang, Z., Zhao, Y., Zhang, L., Ma, B., Wang, H., Matthews, S., Wang, Y. & Zhang, K. (2021). Nucleic Acids Res. 49, 11367-11378.]; Nedal et al., 2020[Nedal, A., Raeder, S. B., Dalhus, B., Helgesen, E., Forstrøm, R. J., Lindland, K., Sumabe, B. K., Martinsen, J. H., Kragelund, B. B., Skarstad, K., Bjørås, M. & Otterlei, M. (2020). Nucleic Acids Res. 48, 5540-5554.]; Pandey et al., 2017[Pandey, P., Verma, V., Gautam, G., Kumari, N., Dhar, S. K. & Gourinath, S. (2017). FEBS Lett. 591, 2311-2322.]). The sliding clamp is one of the earliest reported proteins to have its three-dimensional structure determined, and has been described in many species, including humans, eukaryotes and bacteria (Georgescu et al., 2008[Georgescu, R. E., Kim, S. S., Yurieva, O., Kuriyan, J., Kong, X. P. & O'Donnell, M. (2008). Cell, 132, 43-54. ]; Gulbis et al., 1996[Gulbis, J. M., Kelman, Z., Hurwitz, J., O'Donnell, M. & Kuriyan, J. (1996). Cell, 87, 297-306.]; Williams et al., 2006[Williams, G. J., Johnson, K., Rudolf, J., McMahon, S. A., Carter, L., Oke, M., Liu, H., Taylor, G. L., White, M. F. & Naismith, J. H. (2006). Acta Cryst. F62, 944-948.]). The sliding clamp is widely present in the three major domains of living organisms, forming a β-clamp dimer in bacteria and a PCNA trimer in eukaryotes. In these two domains, a single PCNA or β-clamp gene is present in the genome, and the sliding clamp refers to a homo-complex. In the archaeal domain, Euryarchaeota form homotrimers encoded by a single gene, whereas some species belonging to the Crenarchaeota family have multiple PCNAs that form heterotrimers and homotrimers (MacNeill, 2016[MacNeill, S. A. (2016). Curr. Genet. 62, 527-532.]).

Aeropyrum pernix is a crenarchaeon that inhabits high-temperature and aerobic conditions and was discovered on Kodakara-Jima Island, Japan (Sako et al., 1996[Sako, Y., Nomura, N., Uchida, A., Ishida, Y., Morii, H., Koga, Y., Hoaki, T. & Maruyama, T. (1996). Int. J. Syst. Bacteriol. 46, 1070-1077.]). Analysis of the A. pernix genome showed that the sequence contains three PCNA genes (Kawarabayasi et al., 1999[Kawarabayasi, Y., Hino, Y., Horikawa, H., Yamazaki, S., Haikawa, Y., Jin-no, K., Takahashi, M., Sekine, M., Baba, S., Ankai, A., Kosugi, H., Hosoyama, A., Fukui, S., Nagai, Y., Nishijima, K., Nakazawa, H., Takamiya, M., Masuda, S., Funahashi, T., Tanaka, T., Kudoh, Y., Yamazaki, J., Kushida, N., Oguchi, A., Aoki, K., Kubota, K., Nakamura, Y., Nomura, N., Sako, Y. & Kikuchi, H. (1999). DNA Res. 6, 83-101.]): ApePCNA1 (APE_0162), ApePCNA2 (APE_0441.1) and ApePCNA3 (APE_2182) in the KEGG database (Kanehisa et al., 2017[Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. (2017). Nucleic Acids Res. 45, D353-D361.]). Of the A. pernix genes, approximately 30% have an ATG start codon, approximately 50% have a TTG start codon and 20% have a GTG start codon (Yamazaki et al., 2006[Yamazaki, S., Yamazaki, J., Nishijima, K., Otsuka, R., Mise, M., Ishikawa, H., Sasaki, K., Tago, S. & Isono, K. (2006). Mol. Cell. Proteomics, 5, 811-823.]). The start codon of the APE_0162 gene is GTG, and the molecular weights of the recombinant and native (cell-extract) proteins are identical on sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE; Daimon et al., 2002[Daimon, K., Kawarabayasi, Y., Kikuchi, H., Sako, Y. & Ishino, Y. (2002). J. Bacteriol. 184, 687-694.]). The sliding clamp of A. pernix forms heterotrimers and enhances polymerase activity in the ApePCNA1–ApePCNA2–ApePCNA3 and ApePCNA2–ApePCNA3 complexes (Imamura et al., 2007[Imamura, K., Fukunaga, K., Kawarabayasi, Y. & Ishino, Y. (2007). Mol. Microbiol. 64, 308-318.]). ApePCNA1 is expressed in A. pernix cells but is not essential for its in vitro activity. However, the specific activity of ApePCNA1 has not been determined, and its three-dimensional structure has not yet been analyzed. In this study, we determined the crystal structure of ApePCNA1 and described its features.

2. Materials and methods

2.1. Macromolecule production

The APE_0162 gene encoding ApePCNA1 from A. pernix K1T was amplified from the genomic DNA of strain NBRC 100138T (obtained from NBRC, NITE, Kisarazu, Japan) using polymerase chain reaction (PCR). The PCR product was treated with the NdeI and BglII restriction enzymes and was subcloned into pET-11a vector (Merck KGaA, Darmstadt, Germany). The plasmid was introduced into Escherichia coli Rosetta-gami (DE3) cells by electroporation on ice for 4 ms at 1.80 kV and 25 µF; the cells were incubated in Super Optimal broth with catabolite repression at 310 K for 30 min and spread onto Luria–Bertani (LB) agar containing ampicillin and chloramphenicol. A colony was selected and grown as a primary culture in 15 ml LB broth (Lennox) containing 50 µg ml−1 ampicillin and 34 µg ml−1 chloramphenicol for 9 h at 310 K. Subsequently, 7.5 ml bacterial suspension from the primary culture was grown in 1 l 1% Bacto tryptone (Becton, Dickinson & Co., Franklin Lakes, New Jersey, USA), 0.5% peptone (Kyokuto Pharmaceutical Industrial, Tokyo, Japan), 0.5% sodium chloride, 50 µg ml−1 ampicillin and 34 µg ml−1 chloramphenicol for 12 h at 310 K. The cells were cultured to an A600 of 0.6, and expression of the APE_0162 gene was induced by adding 10% lactose to a final concentration of 0.4%. Cultivation continued for a further 4 h at 310 K.

The cells were harvested, resuspended in 20 mM Tris–HCl pH 8.0, 50 mM NaCl, disrupted by sonication and heated for 30 min at 353 K. Heat-resistant fractions were obtained by centrifugation (8000g for 15 min at 277 K). Soluble proteins were precipitated using 40% saturated ammonium sulfate. The precipitate was resuspended in 10 ml 20 mM Tris–HCl pH 8.0 and dialyzed three times against 1 l 20 mM Tris–HCl pH 8.0 containing 200 mM NaCl (the three dialysis times were 30 min, 1 h and overnight). The dialysate was loaded onto a HiTrap Q HP column (5 ml; Cytiva, Marlborough, Massachusetts, USA) and ApePCNA1 protein was eluted with 200–500 mM sodium chloride.

The eluted protein was concentrated to 100 µl by ultrafiltration using an Amicon Ultra-15 10K centrifugal filter (Merck) and applied onto a HiLoad 16/600 Superdex 75 pg column (Cytiva) pre-equilibrated with 20 mM Tris–HCl pH 8.0, 200 mM sodium chloride. The macromolecule-production process is summarized in Table 1[link].

Table 1
Macromolecule-production information

Source organism A. pernix K1T
Expression vector pET-11a
Expression host E. coli Rosetta-gami (DE3)
Complete amino-acid sequence of the construct produced MSSEATLDSEFTDYKAMFRYEAKVFKELVDSVSKILDEGLFIITGEGLRLRGMDPARVALVDIEIPSSSFFDFYMAGDVERVELGVNMETLKGVVARAKKGDQLEVRVREDKVLFIVESVVLRRYLLPNLEVIVDVPEDISLEFDATATVIADVVKKTLRDVELVGDIVEFDAGEDYLSIRSVGPERRRVETRLTRESPALIDLEVKEPATSRYDVGYLKRMLGVAKIAESIELSFSTDKPLKMVFKSPDGSRVTYLLAPSTG
†The hypothetical anchor sequence is underlined.

2.2. Crystallization

Purified ApePCNA1 was concentrated to 10 mg ml−1 via ultrafiltration using an Amicon Ultra 10K centrifugal filter. The buffer solution was changed to 20 mM Tris–HCl pH 8.0 at the same time. Crystallization was performed by hanging-drop vapor diffusion in a VDX Plate with sealant (Hampton Research, Aliso Viejo, California, USA) at 298 K. The initial crystallization conditions were screened using Wizard Classics 1 and 2 (Rigaku Reagents, The Woodlands, Texas, USA) and Index (Hampton Research). Finally, colorless, origami shuriken-shaped (paper ninja star-like) crystals grew after two days in 100 mM McIlvaine buffer pH 4.2–4.6, 100–250 mM lithium sulfate, 7% propan-2-ol. The crystallization conditions are summarized in Table 2[link].

Table 2
Crystallization

Method Vapor diffusion, hanging drop
Plate type VDX plate
Temperature (K) 298
Protein concentration (mg ml−1) 10
Buffer composition of protein solution 20 mM Tris–HCl pH 8.0
Composition of reservoir solution McIlvaine buffer, lithium sulfate, propan-2-ol
Volume and ratio of drop 4 µl, 1:1
Volume of reservoir (µl) 1000

2.3. Data collection and processing

The ApePCNA1 crystals were collected and packed into a Universal V1-Puck at 77 K in liquid nitrogen. Diffraction data for ApePCNA1 were collected on BL-1A at the Photon Factory, Tsukuba, Japan. The diffraction images were processed (indexed, integrated, scaled and merged) using XDSGUI (Brehm et al., 2023[Brehm, W., Triviño, J., Krahn, J. M., Usón, I. & Diederichs, K. (2023). J. Appl. Cryst. 56, 1585-1594.]). The data-collection statistics are summarized in Table 3[link].

Table 3
Data collection and processing

Values in parentheses are for the outer shell.

Diffraction source Beamline BL-1A, Photon Factory
Wavelength (Å) 1.1000
Temperature (K) 100
Detector Dectris EIGER X 4M
Crystal-to-detector distance (mm) 92.260
Rotation range per image (°) 1
Total rotation range (°) 180
Exposure time per image (s) 10
Space group P43212
a, b, c (Å) 69.03, 69.03, 120.86
α, β, γ (°) 90, 90, 90
Mosaicity (°) 0.138
Resolution range (Å) 48.86–2.00 (2.05–2.00)
Total No. of reflections 258157 (12621)
No. of unique reflections 20481 (1056)
Completeness (%) 100.0 (100.0)
Multiplicity 12.5 (13.4)
I/σ(I)〉 34.4 (15.0)
Rmerge 0.048 (0.164)
Rr.i.m. 0.051 (0.177)
Rp.i.m.§ 0.019 (0.067)
Overall B factor from Wilson plot (Å2) 19.354
Rmerge = [\textstyle \sum_{hkl}\sum_{i}|I_{i}(hkl)- \langle I(hkl)\rangle|/][\textstyle \sum_{hkl}\sum_{i}I_{i}(hkl)], where I(hkl) is the intensity of reflection hkl.
Rr.i.m. = [\textstyle \sum_{hkl}\{N(hkl)/[N(hkl)-1]\}^{1/2}\sum_{i}|I_{i}(hkl)- \langle I(hkl)\rangle|/][\textstyle \sum_{hkl}\sum_{i}I_{i}(hkl)], where N(hkl) is the data multiplicity.
§Rp.i.m. = [\textstyle \sum_{hkl}\{1/[N(hkl)-1]\}^{1/2}\sum_{i}|I_{i}(hkl)- \langle I(hkl)\rangle|/][\textstyle \sum_{hkl}\sum_{i}I_{i}(hkl)].

2.4. Structure solution and refinement

Phases were determined by molecular replacement using MOLREP (Vagin & Teplyakov, 2010[Vagin, A. & Teplyakov, A. (2010). Acta Cryst. D66, 22-25.]) and the PCNA model from Pyrococcus furiosus (PDB entry 1iz4; Matsumiya et al., 2001[Matsumiya, S., Ishino, Y. & Morikawa, K. (2001). Protein Sci. 10, 17-23.]). The model was rebuilt using ARP/wARP Classic (Langer et al., 2008[Langer, G., Cohen, S. X., Lamzin, V. S. & Perrakis, A. (2008). Nat. Protoc. 3, 1171-1179.]) and 92 water molecules were added. The structure was modified using Coot (Emsley et al., 2010[Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486-501.]) and refined using REFMAC5 (Murshudov et al., 2011[Murshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F. & Vagin, A. A. (2011). Acta Cryst. D67, 355-367.]). These processes were performed within the CCP4i interface (Potterton et al., 2003[Potterton, E., Briggs, P., Turkenburg, M. & Dodson, E. (2003). Acta Cryst. D59, 1131-1137.]) using the CCP4 suite (Agirre et al., 2023[Agirre, J., Atanasova, M., Bagdonas, H., Ballard, C. B., Baslé, A., Beilsten-Edmands, J., Borges, R. J., Brown, D. G., Burgos-Mármol, J. J., Berrisford, J. M., Bond, P. S., Caballero, I., Catapano, L., Chojnowski, G., Cook, A. G., Cowtan, K. D., Croll, T. I., Debreczeni, J. É., Devenish, N. E., Dodson, E. J., Drevon, T. R., Emsley, P., Evans, G., Evans, P. R., Fando, M., Foadi, J., Fuentes-Montero, L., Garman, E. F., Gerstel, M., Gildea, R. J., Hatti, K., Hekkelman, M. L., Heuser, P., Hoh, S. W., Hough, M. A., Jenkins, H. T., Jiménez, E., Joosten, R. P., Keegan, R. M., Keep, N., Krissinel, E. B., Kolenko, P., Kovalevskiy, O., Lamzin, V. S., Lawson, D. M., Lebedev, A. A., Leslie, A. G. W., Lohkamp, B., Long, F., Malý, M., McCoy, A. J., McNicholas, S. J., Medina, A., Millán, C., Murray, J. W., Murshudov, G. N., Nicholls, R. A., Noble, M. E. M., Oeffner, R., Pannu, N. S., Parkhurst, J. M., Pearce, N., Pereira, J., Perrakis, A., Powell, H. R., Read, R. J., Rigden, D. J., Rochira, W., Sammito, M., Sánchez Rodríguez, F., Sheldrick, G. M., Shelley, K. L., Simkovic, F., Simpkin, A. J., Skubak, P., Sobolev, E., Steiner, R. A., Stevenson, K., Tews, I., Thomas, J. M. H., Thorn, A., Valls, J. T., Uski, V., Usón, I., Vagin, A., Velankar, S., Vollmar, M., Walden, H., Waterman, D., Wilson, K. S., Winn, M. D., Winter, G., Wojdyr, M. & Yamashita, K. (2023). Acta Cryst. D79, 449-461.]). The ApePCNA1 structure was validated using Coot and the wwPDB validation services (Young et al., 2017[Young, J. Y., Westbrook, J. D., Feng, Z., Sala, R., Peisach, E., Oldfield, T. J., Sen, S., Gutmanas, A., Armstrong, D. R., Berrisford, J. M., Chen, L., Chen, M., Di Costanzo, L., Dimitropoulos, D., Gao, G., Ghosh, S., Gore, S., Guranovic, V., Hendrickx, P. M. S., Hudson, B. P., Igarashi, R., Ikegawa, Y., Kobayashi, N., Lawson, C. L., Liang, Y., Mading, S., Mak, L., Mir, M. S., Mukhopadhyay, A., Patwardhan, A., Persikova, I., Rinaldi, L., Sanz-Garcia, E., Sekharan, M. R., Shao, C., Swaminathan, G. J., Tan, L., Ulrich, E. L., van Ginkel, G., Yamashita, R., Yang, H., Zhuravleva, M. A., Quesada, M., Kleywegt, G. J., Berman, H. M., Markley, J. L., Nakamura, H., Velankar, S. & Burley, S. K. (2017). Structure, 25, 536-545.]) during deposition. Figures were constructed using PyMOL (https://www.pymol.org/). The refinement statistics are summarized in Table 4[link].

Table 4
Structure refinement

Values in parentheses are for the outer shell.

Resolution range (Å) 48.86–2.00 (2.052–2.000)
Completeness (%) 99.9
σ Cutoff 2.00
No. of reflections, working set 19446 (1403)
No. of reflections, test set 991 (69)
Final Rwork 0.185 (0.196)
Final Rfree 0.226 (0.251)
Cruickshank DPI 0.1220
No. of non-H atoms
 Protein 1959
 Ligand 0
 Water 63
 Total 2022
R.m.s. deviations
 Bond lengths (Å) 0.014
 Angles (°) 1.583
Average B factors (Å2)
 Protein 29.6
 Water 32.6
Ramachandran plot
 Most favored (%) 98.8
 Allowed (%) 1.2
Rwork = [\textstyle \sum_{hkl}\big ||F_{\rm obs}|-|F_{\rm calc}|\big |/][ \textstyle \sum_{hkl}|F_{\rm obs}|].
Rfree is calculated the same way as Rwork for data omitted from refinement (5% of the reflections in the data set).

3. Results and discussion

3.1. Sequence comparison of PCNAs

The amino-acid sequence identities between ApePCNA1 and ApePCNA2, between ApePCNA2 and ApePCNA3 and between ApePCNA3 and ApePCNA1 were 28.16%, 21.81% and 28.57%, respectively. The average identity among the three PCNAs was 26.18% (Fig. 1[link]). The ApePCNA1 sequence was approximately ten residues longer at the N-terminus than the other two sequences. Similarly, PCNAs from Saccharo­lobus solfataricus contained a long N-terminal region, as in SsoPCNA3 (PDB entry 2ix2, chain C; protein ID AAK40734.1; Williams et al., 2006[Williams, G. J., Johnson, K., Rudolf, J., McMahon, S. A., Carter, L., Oke, M., Liu, H., Taylor, G. L., White, M. F. & Naismith, J. H. (2006). Acta Cryst. F62, 944-948.]). However, the homology between ApePCNA1 and SsoPCNA3 (24.9%) was lower than those between the ApePCNAs, and only Met1 matched the N-terminal region before the second methionine residue of each PCNA (Met17 in ApePCNA1 and Met16 in SsoPCNA3). These long N-terminal amino-acid sequences (ApePCNA1, Q9YFT8; SsoPCNA3, P57765) are considered to be errors in the initial positions in the UniProt database (The UniProt Consortium, 2023[The UniProt Consortium (2023). Nucleic Acids Res. 51, 523-531.]). However, as discussed later, they can be used as anchor sequences.

[Figure 1]
Figure 1
Multiple sequence alignment of ApePCNAs and SsoPCNA3. Helices, β-sheets and the IDCL are represented by coils, arrows and green bars, respectively. Columns with residues that are more than 70% similar according to physicochemical properties (threshold set to 0.7) are framed in blue and amino-acid residues with 100% identity are highlighted by a red background. This figure was created using ESPript 3.0 (Robert & Gouet, 2014[Robert, X. & Gouet, P. (2014). Nucleic Acids Res. 42, W320-W324.]).

3.2. Evaluating the enhanced expression system

ApePCNA1 was effectively expressed in an amino-acid-rich medium that differs from the Lennox LB medium (Lennox, 1955[Lennox, E. S. (1955). Virology, 1, 190-206.]) that is widely used in protein-expression systems. SDS–PAGE showed that the expression in 1% tryptone, 0.5% peptone, 0.5% NaCl broth (TP broth) was higher than that in Lennox LB medium (Fig. 2[link]). Furthermore, the expression of E. coli-derived proteins (other than the target proteins) was significantly lower in this medium than in conventional LB medium. This medium is mostly composed of amino acids, which limit energy and nucleic acid metabolism. For example, the expression of these metabolism-related proteins is reduced owing to the extremely low amount of nucleic acids in the medium, since the de novo pathway is dominant in nucleic acid metabolism and the salvage pathway is of little significance. Therefore, the specificity of the expression levels of the target proteins may be attributed to the reduced expression of proteins required for their metabolism. We examined the timing of lactose addition by inducing protein expression using the lac operon. Considering the simplicity of this technique and the risk of contamination during incubation, it is preferable to mix lactose with the culture medium and sterilize it at the time of use, rather than separately preparing and sterilizing the culture medium and lactose solution before mixing them. However, the growth rate of the host E. coli was suppressed when ApePCNA1 was overexpressed in a medium containing lactose, and the incubation time required for the solution to reach visually observable turbidity doubled to 26 h. Thus, the premix protocol was unsuitable for E. coli growth. To resolve this issue, lactose was added after E. coli reached an A600 of 0.6, which facilitated the successful growth of E. coli cells overexpressing ApePCNA1.

[Figure 2]
Figure 2
Comparison of ApePCNA1 expression between the two media. In the SDS–PAGE image, the molecular-weight marker (lane M) is on the left, TP medium (lane TP) is in the middle and Lennox LB medium (lane LBL) is on the right. Supernatants (lanes HS) of each sample with the same weight were compared after heat treatment.

3.3. Crystal structure of ApePCNA1

ApePCNA1 crystals diffracted to a maximum of 1.59 Å resolution and the final structure was determined at a resolution of 2.00 Å (Fig. 3[link]). The final resolution cutoff was 2.0 Å, because the Rmarge and I/σ(I) showed abnormal values in the resolution range 1.96–1.66 Å, although the statistics for the outer shell (resolution range 1.66–1.59 Å) were normal. Most amino-acid residues of ApePCNA1 (except for the N-terminal Met1-Ser2-Ser3-Glu4 and the C-terminal Gly263) were assigned in the final structure. The crystal structure contains a single ApePCNA1 subunit within the asymmetric unit. The crystals did not contain a threefold axis and the subunits did not form a ring-shaped trimeric structure. The ApePCNA1 subunit is composed of N- and C-terminal domains and a long loop called the inter-domain-connecting loop (IDCL) that connects the two domains formed by Leu130–Gln145. The N- and C-terminal domains consist of two β-sheets and two α-helices. In the N-terminal domains, each β-strand (β5, β1, β7, β8, β9 and β6, β2, β3, β4) forms small β-sheets. In the C-terminal domains, β15, β11, β12, β13 and β14, β10, β16, β17, β18 form β-sheets. One of the two β-sheets in each domain is linked to a β-sheet in the neighboring domain in the same molecule to form a large continuous β-sheet (β6, β2, β3, β4, β18, β17, β16, β10, β14). Therefore, the ApePCNA1 subunit contains one large β-sheet and two small β-sheets. All of these β-sheets are arranged in an antiparallel manner. The four α-helices are arranged in an inverse parallel manner and are positively charged. Of these, η2 follows α4 to form a tighter helix. The individual β-strands that make up the large β-sheet are aligned parallel to the antiparallel α-helices, but although the middle of the sheet is close, the edges of the sheet are further away from the α-helices. The two small β-sheets that do not belong to the large β-sheet are arranged so that one covers one end of the large β-sheet and the other covers one end of the α-helices. The inner side of the ApePCNA1 subunit surrounded by these secondary structures is rich in hydrophobic residues that form a series of hydrophobic inter­actions (Fig. 4[link]a). Cavity regions are present near the contacts between the two sides and the dorsal β-sheet (Fig. 4[link]b). A cavity is also present between the C-terminal side of the IDCL region and the back β-sheet, which is rich in hydrophobic residues. The overall structure is similar to those of the homotrimeric ring of human PCNA (PDB entry 1axc; Gulbis et al., 1996[Gulbis, J. M., Kelman, Z., Hurwitz, J., O'Donnell, M. & Kuriyan, J. (1996). Cell, 87, 297-306.]), a monomer of the PCNA ring from yeast (PDB entry 1plq; Krishna et al., 1994[Krishna, T. S., Kong, X. P., Gary, S., Burgers, P. M. & Kuriyan, J. (1994). Cell, 79, 1233-1243.]) and a PCNA monomer from the thermophilic archaeon P. furiosus (PDB entry 1ge8; Matsumiya et al., 2001[Matsumiya, S., Ishino, Y. & Morikawa, K. (2001). Protein Sci. 10, 17-23.]). Structural alignment was performed for these PCNAs (human PCNA, yeast PCNA and P. furiosus PCNA). PyMOL was used for the alignment, which was performed using Cα atoms. The r.m.s.d.s for each were 1.178 Å (the average value for the trimer), 1.061 Å and 0.881 Å, respectively.

[Figure 3]
Figure 3
Stereoview of the ApePCNA1 structure. The protein is depicted as a ribbon diagram, with the α-helices, β-sheets, loops and IDCL colored red, marine blue, gray and green, respectively.
[Figure 4]
Figure 4
Structural features of ApePCNA1. (a) Hydrophobic amino acids are shown as green sticks. (b) Cavity regions are shown as green meshes. The cavities were drawn using PyMOL. (c) Electrostatic potentials on the molecular surface are shown in blue and red for positive and negative charge, respectively. (a), (b) and (c) are viewed from the same orientation as in Fig. 3[link]. (d) Model of the ApePCNA1 homotrimeric ring viewed from the threefold axis direction. Each subunit is colored differently.

3.4. Interaction of ApePCNA1 with other molecules

The PCNA rings from other species have an inward α-helix region (Li et al., 2021[Li, H., Zheng, F. & O'Donnell, M. (2021). FEBS J. 288, 7256-7262.]). The positive surface charge of the α-helix region suggests that ApePCNA1 has an α-helix region located in the inner part of the ring that interacts with the negative charge of the DNA double helix like that in other species (Fig. 4[link]c). The trimeric ring model based on the structure of ApePCNA1 is connected by two adjacent small β-sheets between each subunit (Fig. 4[link]d). In addition, the long N-terminus may be disordered in aqueous solution, suggesting that it does not form a homotrimer. This insight follows the results of gel-filtration analysis in a previous study (Imamura et al., 2007[Imamura, K., Fukunaga, K., Kawarabayasi, Y. & Ishino, Y. (2007). Mol. Microbiol. 64, 308-318.]). The IDCL region of PDB-deposited PCNAs is a movable, partially unfolded loop that often has a disordered structure. In contrast, electron density was observed in the IDCL region of ApePCNA1. Contrary to our expectations, clear electron density was observed at the N-terminus of ApePCNA1, which was expected to be a partially unfolded loop owing to its length. These long loops are the contact points of the adjacent subunits related to the screw axis in the space group (P43212) of the crystal. In general, the C-terminal side of the sliding clamp is considered to be the direction of DNA replication, and a group of enzymes responsible for DNA replication bind to the binding pocket near the IDCL (González-Magaña & Blanco, 2020[González-Magaña, A. & Blanco, F. J. (2020). Biomolecules, 10, 570.]). Interestingly, the N-terminus of ApePCNA1 interacted with the cleavage groove of the adjacent ApePCNA1 molecule (Fig. 5[link]a). In this interaction, the carboxyl group of the N-terminal Asp8 is connected to Arg57 of the neighboring subunit by a hydrogen bond. Additionally, the NH of the main chain of Leu7 formed a hydrogen bond to the CO of the main chain of Arg57 in the neighboring subunit. The hydrophobic side chain of Leu7 is placed in a hydrophobic pocket formed by Met53, Leu60, Pro137, Pro241, Leu257 and Ala259 in an adjacent subunit. This interaction is like that observed between human PCNA and UHRF2PIP (PDB entry 5yco; Chen et al., 2017[Chen, W., Wu, M., Hang, T., Wang, C., Zhang, X. & Zang, J. (2017). Biochem. Biophys. Res. Commun. 494, 575-580.]; Fig. 5[link]b). The consensus sequence of the PIP-box is QXXhXXaa, where X is any amino acid, h is a hydrophobic amino acid and a is an aromatic amino acid. The 4-EATLDSEF-11 sequence in the N-terminal region of ApePCNA1 is similar to the consensus sequence of the PIP-box (Fig. 5[link]c). These results suggest that the PIP-box binding site of ApePCNA1 is in a similar location and binds in an analogous manner to those of PCNAs from other species. Furthermore, the N-terminal region of ApePCNA1 was suggested to be an anchor sequence that induces PIP-box binding. These results suggest that ApePCNA1 has an unknown function mediated by an N-terminal anchor sequence that results in PIP-box-like interactions.

[Figure 5]
Figure 5
Comparison of the PCNA structures and PIP-box sequences. (a) Omit FoFc difference map (blue mesh) calculated without the N-terminus of ApePCNA1 (orange) contoured at 2σ. The ICDL is colored green and red dashes represent hydrogen bonds. (b) Human PCNA with UHRF2PIP (PDB entry 5yco) is shown in the same orientation as in (a). (c) The PIP-box consensus sequence was compared with the N-terminal sequence of ApePCNA1 and proteins with the PIP-box sequence [PDB entries 1u7b (Bruning & Shamoo, 2004[Bruning, J. B. & Shamoo, Y. (2004). Structure, 12, 2209-2219.]) and 2zvv (Strzalka et al., 2009[Strzalka, W., Oyama, T., Tori, K. & Morikawa, K. (2009). Protein Sci. 18, 1072-1080.])].

In conclusion, we determined the crystal structure of ApePCNA1. A unique interaction via the N-terminus (which contains a PIP-box-like sequence) may be involved in the uncharacterized DNA-replication machinery in thermophilic archaea. We developed a new approach using a modified medium and protocol to express recombinant proteins containing the lac operon. These findings may be useful for protein research.

Footnotes

Present address: Structural Biology Research Center, Institute of Materials Structure Science, High Energy Accelerator Research Organization, KEK, Japan.

Acknowledgements

We thank Professor T. Senda of the Structural Biology Research Center (SBRC), Professor N. Matsugaki, Dr Y. Yamada and Dr M. Hikita for their support with data collection at the Photon Factory of the High Energy Accelerator Research Organization (KEK), Japan. We thank Editage (https://www.editage.com) for English language editing.

Funding information

This study was funded by the National Project on Protein Structural and Functional Analysis of the Ministry of Education, Culture, Sports, Science and Technology of Japan.

References

First citationAgirre, J., Atanasova, M., Bagdonas, H., Ballard, C. B., Baslé, A., Beilsten-Edmands, J., Borges, R. J., Brown, D. G., Burgos-Mármol, J. J., Berrisford, J. M., Bond, P. S., Caballero, I., Catapano, L., Chojnowski, G., Cook, A. G., Cowtan, K. D., Croll, T. I., Debreczeni, J. É., Devenish, N. E., Dodson, E. J., Drevon, T. R., Emsley, P., Evans, G., Evans, P. R., Fando, M., Foadi, J., Fuentes-Montero, L., Garman, E. F., Gerstel, M., Gildea, R. J., Hatti, K., Hekkelman, M. L., Heuser, P., Hoh, S. W., Hough, M. A., Jenkins, H. T., Jiménez, E., Joosten, R. P., Keegan, R. M., Keep, N., Krissinel, E. B., Kolenko, P., Kovalevskiy, O., Lamzin, V. S., Lawson, D. M., Lebedev, A. A., Leslie, A. G. W., Lohkamp, B., Long, F., Malý, M., McCoy, A. J., McNicholas, S. J., Medina, A., Millán, C., Murray, J. W., Murshudov, G. N., Nicholls, R. A., Noble, M. E. M., Oeffner, R., Pannu, N. S., Parkhurst, J. M., Pearce, N., Pereira, J., Perrakis, A., Powell, H. R., Read, R. J., Rigden, D. J., Rochira, W., Sammito, M., Sánchez Rodríguez, F., Sheldrick, G. M., Shelley, K. L., Simkovic, F., Simpkin, A. J., Skubak, P., Sobolev, E., Steiner, R. A., Stevenson, K., Tews, I., Thomas, J. M. H., Thorn, A., Valls, J. T., Uski, V., Usón, I., Vagin, A., Velankar, S., Vollmar, M., Walden, H., Waterman, D., Wilson, K. S., Winn, M. D., Winter, G., Wojdyr, M. & Yamashita, K. (2023). Acta Cryst. D79, 449–461.  Web of Science CrossRef IUCr Journals Google Scholar
First citationBrehm, W., Triviño, J., Krahn, J. M., Usón, I. & Diederichs, K. (2023). J. Appl. Cryst. 56, 1585–1594.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationBruning, J. B. & Shamoo, Y. (2004). Structure, 12, 2209–2219.  Web of Science CrossRef PubMed CAS Google Scholar
First citationChen, W., Wu, M., Hang, T., Wang, C., Zhang, X. & Zang, J. (2017). Biochem. Biophys. Res. Commun. 494, 575–580.  Web of Science CrossRef CAS PubMed Google Scholar
First citationChen, X., Sun, J. & Wang, Y. (2021). J. BUON, 26, 72–78.  Web of Science PubMed Google Scholar
First citationDaimon, K., Kawarabayasi, Y., Kikuchi, H., Sako, Y. & Ishino, Y. (2002). J. Bacteriol. 184, 687–694.  Web of Science CrossRef PubMed CAS Google Scholar
First citationEmsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta Cryst. D66, 486–501.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationGeorgescu, R. E., Kim, S. S., Yurieva, O., Kuriyan, J., Kong, X. P. & O'Donnell, M. (2008). Cell, 132, 43–54.   Web of Science CrossRef PubMed CAS Google Scholar
First citationGonzález-Magaña, A. & Blanco, F. J. (2020). Biomolecules, 10, 570.  Web of Science PubMed Google Scholar
First citationGulbis, J. M., Kelman, Z., Hurwitz, J., O'Donnell, M. & Kuriyan, J. (1996). Cell, 87, 297–306.  CrossRef CAS PubMed Web of Science Google Scholar
First citationHorsfall, A. J., Vandborg, B. A., Kowalczyk, W., Chav, T., Scanlon, D. B., Abell, A. D. & Bruning, J. B. (2021). J. Biol. Chem. 296, 100773.  Web of Science CrossRef PubMed Google Scholar
First citationImamura, K., Fukunaga, K., Kawarabayasi, Y. & Ishino, Y. (2007). Mol. Microbiol. 64, 308–318.  Web of Science CrossRef PubMed CAS Google Scholar
First citationKanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. (2017). Nucleic Acids Res. 45, D353–D361.  Web of Science CrossRef CAS PubMed Google Scholar
First citationKawarabayasi, Y., Hino, Y., Horikawa, H., Yamazaki, S., Haikawa, Y., Jin-no, K., Takahashi, M., Sekine, M., Baba, S., Ankai, A., Kosugi, H., Hosoyama, A., Fukui, S., Nagai, Y., Nishijima, K., Nakazawa, H., Takamiya, M., Masuda, S., Funahashi, T., Tanaka, T., Kudoh, Y., Yamazaki, J., Kushida, N., Oguchi, A., Aoki, K., Kubota, K., Nakamura, Y., Nomura, N., Sako, Y. & Kikuchi, H. (1999). DNA Res. 6, 83–101.  CrossRef PubMed CAS Google Scholar
First citationKrishna, T. S., Kong, X. P., Gary, S., Burgers, P. M. & Kuriyan, J. (1994). Cell, 79, 1233–1243.  CrossRef CAS PubMed Web of Science Google Scholar
First citationLanger, G., Cohen, S. X., Lamzin, V. S. & Perrakis, A. (2008). Nat. Protoc. 3, 1171–1179.  Web of Science CrossRef PubMed CAS Google Scholar
First citationLennox, E. S. (1955). Virology, 1, 190–206.  CrossRef PubMed CAS Web of Science Google Scholar
First citationLi, H., Zheng, F. & O'Donnell, M. (2021). FEBS J. 288, 7256–7262.  Web of Science CrossRef CAS PubMed Google Scholar
First citationLiu, B., Li, S., Liu, Y., Chen, H., Hu, Z., Wang, Z., Zhao, Y., Zhang, L., Ma, B., Wang, H., Matthews, S., Wang, Y. & Zhang, K. (2021). Nucleic Acids Res. 49, 11367–11378.  Web of Science CrossRef CAS PubMed Google Scholar
First citationMacNeill, S. A. (2016). Curr. Genet. 62, 527–532.  Web of Science CrossRef CAS PubMed Google Scholar
First citationMaga, G. & Hübscher, U. (2003). J. Cell Sci. 116, 3051–3060.  Web of Science CrossRef PubMed CAS Google Scholar
First citationMatsumiya, S., Ishino, Y. & Morikawa, K. (2001). Protein Sci. 10, 17–23.  Web of Science CrossRef PubMed CAS Google Scholar
First citationMoldovan, G. L., Pfander, B. & Jentsch, S. (2007). Cell, 129, 665–679.   Web of Science CrossRef PubMed CAS Google Scholar
First citationMurshudov, G. N., Skubák, P., Lebedev, A. A., Pannu, N. S., Steiner, R. A., Nicholls, R. A., Winn, M. D., Long, F. & Vagin, A. A. (2011). Acta Cryst. D67, 355–367.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationNedal, A., Raeder, S. B., Dalhus, B., Helgesen, E., Forstrøm, R. J., Lindland, K., Sumabe, B. K., Martinsen, J. H., Kragelund, B. B., Skarstad, K., Bjørås, M. & Otterlei, M. (2020). Nucleic Acids Res. 48, 5540–5554.  Web of Science CrossRef CAS PubMed Google Scholar
First citationPandey, P., Verma, V., Gautam, G., Kumari, N., Dhar, S. K. & Gourinath, S. (2017). FEBS Lett. 591, 2311–2322.  Web of Science CrossRef CAS PubMed Google Scholar
First citationPotterton, E., Briggs, P., Turkenburg, M. & Dodson, E. (2003). Acta Cryst. D59, 1131–1137.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationRobert, X. & Gouet, P. (2014). Nucleic Acids Res. 42, W320–W324.  Web of Science CrossRef CAS PubMed Google Scholar
First citationSako, Y., Nomura, N., Uchida, A., Ishida, Y., Morii, H., Koga, Y., Hoaki, T. & Maruyama, T. (1996). Int. J. Syst. Bacteriol. 46, 1070–1077.  CrossRef CAS PubMed Web of Science Google Scholar
First citationStrzalka, W., Oyama, T., Tori, K. & Morikawa, K. (2009). Protein Sci. 18, 1072–1080.  Web of Science CrossRef PubMed CAS Google Scholar
First citationThe UniProt Consortium (2023). Nucleic Acids Res. 51, 523–531.  Web of Science CrossRef Google Scholar
First citationVagin, A. & Teplyakov, A. (2010). Acta Cryst. D66, 22–25.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationWendel, S. O., Snow, J. A., Gu, L., Banerjee, N. S., Malkas, L. & Wallace, N. A. (2023). J. Med. Virol. 95, e29244.  Web of Science CrossRef PubMed Google Scholar
First citationWilliams, G. J., Johnson, K., Rudolf, J., McMahon, S. A., Carter, L., Oke, M., Liu, H., Taylor, G. L., White, M. F. & Naismith, J. H. (2006). Acta Cryst. F62, 944–948.  Web of Science CrossRef IUCr Journals Google Scholar
First citationWinter, J. A. & Bunting, K. A. (2012). Archaea, 2012, 951010.  Web of Science PubMed Google Scholar
First citationYamazaki, S., Yamazaki, J., Nishijima, K., Otsuka, R., Mise, M., Ishikawa, H., Sasaki, K., Tago, S. & Isono, K. (2006). Mol. Cell. Proteomics, 5, 811–823.  Web of Science CrossRef PubMed CAS Google Scholar
First citationYao, N. Y. & O'Donnell, M. E. (2016). Crit. Rev. Biochem. Mol. Biol. 51, 135–149.  Web of Science CrossRef CAS PubMed Google Scholar
First citationYoung, J. Y., Westbrook, J. D., Feng, Z., Sala, R., Peisach, E., Oldfield, T. J., Sen, S., Gutmanas, A., Armstrong, D. R., Berrisford, J. M., Chen, L., Chen, M., Di Costanzo, L., Dimitropoulos, D., Gao, G., Ghosh, S., Gore, S., Guranovic, V., Hendrickx, P. M. S., Hudson, B. P., Igarashi, R., Ikegawa, Y., Kobayashi, N., Lawson, C. L., Liang, Y., Mading, S., Mak, L., Mir, M. S., Mukhopadhyay, A., Patwardhan, A., Persikova, I., Rinaldi, L., Sanz-Garcia, E., Sekharan, M. R., Shao, C., Swaminathan, G. J., Tan, L., Ulrich, E. L., van Ginkel, G., Yamashita, R., Yang, H., Zhuravleva, M. A., Quesada, M., Kleywegt, G. J., Berman, H. M., Markley, J. L., Nakamura, H., Velankar, S. & Burley, S. K. (2017). Structure, 25, 536–545.  Web of Science CrossRef CAS PubMed Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoSTRUCTURAL BIOLOGY
COMMUNICATIONS
ISSN: 2053-230X
Follow Acta Cryst. F
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds